Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Recipe For Doubling Innovative Medicines Includes New Approval Pathway, FDA Management Changes

Oct 01 2012

• By Brenda Sandburg

Related Content

FDA Exploring Limited-Use Approvals For Antibiotics Based On Small Development Programs

Mar 07 2012

BIO Wants Expanded Accelerated Approval In PDUFA Instead Of Progressive Approval

Jan 23 2012

Antibiotic Incentives: FDA’s Woodcock Says LPAD Could Be Better Than Exclusivity, But Questions Remain

Apr 19 2012

PDUFA V: Accelerated Approval Expansion May Outshine Rare Disease Improvements

Sep 17 2012

Related Companies

Pfizer Inc.

Eli Lilly and Company

GSK plc

Sanofi

Additional Topics

United States Regulation Drug Approval Standards Post Market Regulation & Studies BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window